Suppression of colorectal carcinogenesis by naringin

Background: Colorectal cancer is the third most malignant cancer worldwide. Despite novel treatment options, the incidence and mortality rates of colon cancer continue to increase in most countries, especially in US, European and Asian countries. Colorectal carcinogenesis is multifactorial, including dietary and genetic factors, as well as lacking physical activity. Vegetables and fruits contain high amounts of secondary metabolites, which might reduce the risk for colorectal carcinogenesis. Flavonoids are important bioactive polyphenolic compounds. There are more than 4,000 different flavonoids, including flavanones, flavonoids, isoflavonoids, flavones, and catechins in a large variety of plant.Hypothesis: Among various other flavonoids, naringin in Citrus fruits has been a subject of intense scrutiny for its activity against many types of cancer, including colorectal cancer. We hypothesize that naringin is capable to inhibit the growth of transformed colonocytes and to induce programmed cell death in colon cancer cells.Results: We comprehensively review the inhibitory effects of naringin on colorectal cancers and address the underlying mechanistic pathways such as NF-Kappa B/IL-6/STAT3, PI3K/AKT/mTOR, apoptosis, NF-Kappa B-COX-2-iNOS, and beta-catenin pathways.Conclusion: Naringin suppresses colorectal inflammation and carcinogenesis by various signaling pathways. Randomized clinical trials are needed to determine their effectiveness in combating colorectal cancer.

Automated summary

The research focuses on evaluating the inhibitory effects of naringin in citrus fruits on colorectal cancer, as well as its potential mechanistic pathways, including multiple signaling pathways such as NF-Kappa B/IL-6/STAT3, PI3K/AKT/mTOR, apoptosis, NF-Kappa B-COX-2-iNOS, and beta-catenin pathways.